(Q33498215)

27 July 2017

title

Rhabdomyolysis induced by epsilon-aminocaproic acid (English)

1 reference

27 July 2017

1 reference

B D Seymour

1

1 reference

27 July 2017

M Rubinger

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Annals of Pharmacotherapy

27 July 2017

published in

1 reference

27 July 2017

volume

31

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

56-58

1 reference

Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

Aminocaproic acid. Use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

Myopathy from E-aminocaproic acid: a second case

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

Streptokinase clot lysis time in patients with ruptured intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

Intracranial Aneurysms and Subarachnoid Hemorrhage. A Cooperative Study. Antifibrinolytic Therapy in Recent Onset Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100109

10.1177/106002809703100109

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference